John Gillespei is the Clinical Director for this company. He has a MD from George Washington Medical School. He has done a fellowship in pathogenetics in the National Cancer Institute. He worked in numerous projects at the NCI . He has published over 50 articles in high impact cancer journals. He has previously served as the director of medical affairs at 20/20 GeneSystems, Inc. and as a principal scientist in SAIC-Frederick in the NCI.